urea has been researched along with Marfan Syndrome in 3 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Landiolol was useful for reduction of HR without affecting BP or uterine contractions during a Cesarean section procedure in our patient with aortic dissection." | 5.36 | Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section. ( Kawamoto, M; Saeki, N; Taguchi, S, 2010) |
| "Landiolol was useful for reduction of HR without affecting BP or uterine contractions during a Cesarean section procedure in our patient with aortic dissection." | 1.36 | Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section. ( Kawamoto, M; Saeki, N; Taguchi, S, 2010) |
| "Landiolol hydrochloride is a new beta-adrenergic blocker of which greatest advantages are its short duration of action, rapid clearance and high beta 1-selectivity." | 1.32 | [Short-acting beta 1-adrenergic blocker is useful for anesthetic management of cesarean section in a patient with Marfan syndrome]. ( Kamata, K; Morioka, N; Nomura, M; Ozaki, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saeki, N | 1 |
| Taguchi, S | 1 |
| Kawamoto, M | 1 |
| Kamata, K | 1 |
| Morioka, N | 1 |
| Nomura, M | 1 |
| Ozaki, M | 1 |
| Sautter, H | 1 |
| Schroeder, W | 1 |
| Naumann, G | 1 |
3 other studies available for urea and Marfan Syndrome
| Article | Year |
|---|---|
Successful management of a patient with Marfan syndrome complicated with acute aortic dissection using landiolol during Cesarean section.
Topics: Adrenergic beta-Antagonists; Adult; Aortic Aneurysm; Aortic Dissection; Blood Pressure; Cesarean Sec | 2010 |
[Short-acting beta 1-adrenergic blocker is useful for anesthetic management of cesarean section in a patient with Marfan syndrome].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Aorta; Cesarean Sec | 2004 |
[Results of surgical treatment in dislocated lenses. I. Aspiration of dislocated lenses in children and in young persons (author's transl)].
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Homocystinuria; Humans; Intraocular Pressure; La | 1974 |